Clinical trial
Rozerem 8 mg Tablets Specified Drug-use Survey: <Long-term Survey on Insomnia Associated With Sleep-onset Difficulty > - Transitional Survey From the Preceding Drug-use Survey -
NCT02153086 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rozerem 8 mg Tablets Specified Drug-use Survey: <Long-term Survey on Insomnia Associated With Sleep-onset Difficulty > - Transitional Survey From the Preceding Drug-use Survey -
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- June 30, 2014
- Enrollment
- 236 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
insomnia